Pharma & Healthcare

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Research Report 2025

Report Scope
This report aims to provide a comprehensive presentation of the global market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dipeptidyl Peptidase IV (DPP-IV) Inhibitors.
The Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AstraZeneca
Boehringer
Eli Lilly
Merck
Mitsubishi Tanabe Pharma
Novartis
Takeda
Segment by Type
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Overview
1.1 Product Definition
1.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Type
1.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sitagliptin
1.2.3 Vildagliptin
1.2.4 Saxagliptin
1.2.5 Linagliptin
1.2.6 Others
1.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Application
1.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue 2020-2031
1.4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales 2020-2031
1.4.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competition by Manufacturers
2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Date of Enter into This Industry
2.8 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competitive Situation and Trends
2.8.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players Market Share by Revenue
2.8.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Scenario by Region
3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2020-2031
3.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2020-2025
3.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2026-2031
3.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2020-2031
3.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2020-2025
3.3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2026-2031
3.4 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
3.4.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2020-2031)
3.4.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2020-2031)
3.5.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2020-2031)
3.6.3 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2020-2031)
3.7.3 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2020-2031)
4.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2020-2025)
4.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2026-2031)
4.1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2020-2031)
4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2020-2031)
4.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2020-2025)
4.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2026-2031)
4.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2020-2031)
4.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2020-2031)
5.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2020-2025)
5.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2026-2031)
5.1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2020-2031)
5.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2020-2031)
5.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2020-2025)
5.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2026-2031)
5.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2020-2031)
5.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Boehringer
6.2.1 Boehringer Company Information
6.2.2 Boehringer Description and Business Overview
6.2.3 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
6.2.5 Boehringer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Mitsubishi Tanabe Pharma
6.5.1 Mitsubishi Tanabe Pharma Company Information
6.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.5.3 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
6.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Takeda
6.7.1 Takeda Company Information
6.7.2 Takeda Description and Business Overview
6.7.3 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
6.7.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Chain Analysis
7.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Mode & Process Analysis
7.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Marketing
7.4.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Channels
7.4.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors
7.5 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customer Analysis
8 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Dynamics
8.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Trends
8.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
8.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges
8.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) of Key Manufacturers (2020-2025)
Table 5. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2020-2025) & (K MT)
Table 18. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2026-2031) & (K MT)
Table 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2020-2025) & (K MT)
Table 27. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2026-2031) & (K MT)
Table 28. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2020-2025) & (K MT)
Table 32. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2026-2031) & (K MT)
Table 33. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2020-2025) & (K MT)
Table 37. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2026-2031) & (K MT)
Table 38. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2020-2025) & (K MT)
Table 42. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2026-2031) & (K MT)
Table 43. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2020-2025) & (K MT)
Table 47. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2026-2031) & (K MT)
Table 48. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Type (2020-2025)
Table 51. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Type (2026-2031)
Table 52. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Type (2020-2025)
Table 59. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Type (2026-2031)
Table 60. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Application (2020-2025)
Table 61. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT) by Application (2026-2031)
Table 62. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Application (2020-2025)
Table 69. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Application (2026-2031)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Boehringer Company Information
Table 76. Boehringer Description and Business Overview
Table 77. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 79. Boehringer Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 89. Merck Recent Developments/Updates
Table 90. Mitsubishi Tanabe Pharma Company Information
Table 91. Mitsubishi Tanabe Pharma Description and Business Overview
Table 92. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 94. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 99. Novartis Recent Developments/Updates
Table 100. Takeda Company Information
Table 101. Takeda Description and Business Overview
Table 102. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
Table 104. Takeda Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors List
Table 108. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers List
Table 109. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Trends
Table 110. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
Table 111. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges
Table 112. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report


List of Figures
Figure 1. Product Picture of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors
Figure 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Sitagliptin Product Picture
Figure 5. Vildagliptin Product Picture
Figure 6. Saxagliptin Product Picture
Figure 7. Linagliptin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Application: 2024 & 2031
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (2020-2031) & (K MT)
Figure 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price (USD/MT) & (2020-2031)
Figure 18. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Report Years Considered
Figure 19. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Manufacturers in 2024
Figure 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players: Market Share by Revenue in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in 2024
Figure 22. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2020-2031)
Figure 25. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2020-2031)
Figure 29. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2020-2031)
Figure 30. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2020-2031)
Figure 37. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2020-2031)
Figure 48. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Type (2020-2031)
Figure 58. Global Revenue Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Type (2020-2031)
Figure 59. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Type (2020-2031)
Figure 60. Global Sales Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Application (2020-2031)
Figure 61. Global Revenue Market Share of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Application (2020-2031)
Figure 62. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (USD/MT) by Application (2020-2031)
Figure 63. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies